.After pushing the selection date for Applied Therapies' metabolic condition medicine govorestat, th...
.Novo Nordisk is actually continuing its own press in to hereditary medicines, agreeing to compensat...
.Innovent Biologics has produced the situation that its own checkpoint inhibitor-cytokine combinatio...
.A phase 3 trial of Daiichi Sankyo and also Merck & Co.'s HER3-directed antibody-drug conjugate (...
.Five months after Rakovina Rehabs rotated toward expert system, the cancer-focused biotech has join...
.Ascendis Pharma has become a potential hazard to BioMarin's Voxzogo, disclosing period 3 growth ail...
.Though Alkeus Pharmaceuticals' oral eye illness asset stopped working to considerably lessen geogra...
.With a trio of biotechs hitting the Nasdaq on Friday, it was effortless to overlook a smaller-scale...
.Invulnerable checkpoint inhibitors are actually the superheroes of cancer cells treatment. Drugs li...
.Accept to today's Chutes & Ladders, our summary of significant leadership hirings, firings as we...